Deboprosad M.

Deboprosad M. has a diverse background in research and teaching roles. Deboprosad began their career as a Graduate Research and Teaching Assistant at Florida Atlantic University from 2004 to 2010, where they successfully developed and synthesized new types of leaving groups and conducted research on mild halogenation and amidation reactions. During this time, they also worked as a Lecturer, teaching undergraduate organic courses.

Following their time at Florida Atlantic University, Deboprosad M. joined The Scripps Research Institute - Florida campus as a Postdoctoral Research Associate from 2011 to 2015. Under the guidance of Prof. William R. Roush, they focused on structure-based and fragment-based drug design, improving drug properties, and developing potent anti-parasitic drugs.

In 2015, Deboprosad M. joined Baylor University as a Postdoctoral Research Associate, working under Prof. Kevin G. Pinney. Their research there involved the development of selective cancer therapeutics, including synthesis routes for antibody-drug conjugates (ADCs) and bioreductively activatable prodrug conjugates (BAPCs). Deboprosad also mentored graduate students and helped solve synthetic problems.

Since 2017, Deboprosad M. has been working at Noven Pharmaceuticals. Deboprosad initially started as a Research Scientist and later advanced to the role of Senior Research Scientist in 2021. Details about their specific contributions and responsibilities in these positions were not provided.

Additionally, in 2020, they had an affiliated role as a Research Scientist at Florida Atlantic University, although no specific details were mentioned.

Deboprosad M. began their education in 1997 at Diamond Harbour, where they completed their Higher Secondary degree in Science in 1999. Deboprosad then went on to pursue their Master of Science (M.Sc) degree in Physical, Organic, Inorganic, and Biochemistry from the Indian Institute of Technology, Kanpur, from 2002 to 2004. Following this, Deboprosad M. enrolled in Florida Atlantic University from 2004 to 2010, where they obtained their Doctor of Philosophy (PhD) degree in Organic Synthesis and Methodology.